Colloidal polymer-coated Zn-doped iron oxide nanoparticles with high relaxivity and specific absorption rate for efficient magnetic resonance imaging and magnetic hyperthermia.

Cancer theranostic High relaxivity High specific absorption rate Iron oxide nanoparticle Polymer coating Superparamagnetism Zinc doping

Journal

Journal of colloid and interface science
ISSN: 1095-7103
Titre abrégé: J Colloid Interface Sci
Pays: United States
ID NLM: 0043125

Informations de publication

Date de publication:
01 Nov 2020
Historique:
received: 06 02 2020
revised: 29 05 2020
accepted: 30 05 2020
pubmed: 27 6 2020
medline: 22 6 2021
entrez: 27 6 2020
Statut: ppublish

Résumé

Colloidally stable nanoparticles-based magnetic agents endowed with very high relaxivity and specific absorption rate are extremely desirable for efficient magnetic resonance imaging and magnetic hyperthermia, respectively. Here, we report a water dispersible magnetic agent consisting of zinc-doped superparamagnetic iron oxide nanoparticles (i.e., Zn-SPIONs) of 15 nm size with high saturation magnetization coated with an amphiphilic polymer for effective magnetic resonance imaging and magnetic hyperthermia of glioblastoma cells. These biocompatible polymer-coated Zn-SPIONs had 24 nm hydrodynamic diameter and exhibited high colloidal stability in various aqueous media, very high transverse relaxivity of 471 mM

Identifiants

pubmed: 32590159
pii: S0021-9797(20)30735-9
doi: 10.1016/j.jcis.2020.05.119
pii:
doi:

Substances chimiques

Contrast Media 0
Magnetite Nanoparticles 0
Polymers 0
Zinc J41CSQ7QDS

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

186-194

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Pradip Das (P)

NanoBioLab, Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy; Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.

Lucia Salvioni (L)

NanoBioLab, Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy.

Manuela Malatesta (M)

Neurosciences, Biomedicine and Movement Dept., School of Medicine, University of Verona, Strada le grazie 8, 37134 Verona, Italy.

Federica Vurro (F)

Computer Sciences Dept., University of Verona, Strada le grazie 7, Verona, Italy.

Silvia Mannucci (S)

Neurosciences, Biomedicine and Movement Dept., School of Medicine, University of Verona, Strada le grazie 8, 37134 Verona, Italy.

Marco Gerosa (M)

Computer Sciences Dept., University of Verona, Strada le grazie 7, Verona, Italy.

Maria Antonietta Rizzuto (M)

NanoBioLab, Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy.

Chiara Tullio (C)

NanoBioLab, Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy.

Anna Degrassi (A)

Toxicology, Accelera S.R.L. - NMS Group S.p.A., Viale Pasteur 10, 20014 Nerviano, MI, Italy.

Miriam Colombo (M)

NanoBioLab, Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy. Electronic address: miriam.colombo@unimib.it.

Anna M Ferretti (AM)

Istituto di Scienze e Tecnologie Chimiche "Giulio Natta" (SCITEC), Consiglio Nazionale delle Ricerche, via G, Fantoli 16/15, 20138 Milano, Italy.

Alessandro Ponti (A)

Istituto di Scienze e Tecnologie Chimiche "Giulio Natta" (SCITEC), Consiglio Nazionale delle Ricerche, via G, Fantoli 16/15, 20138 Milano, Italy.

Laura Calderan (L)

Neurosciences, Biomedicine and Movement Dept., School of Medicine, University of Verona, Strada le grazie 8, 37134 Verona, Italy.

Davide Prosperi (D)

NanoBioLab, Dipartimento di Biotecnologie e Bioscienze, Università di Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy; Nanomedicine Laboratory, ICS Maugeri S.p.A. SB, via S. Maugeri 10, 27100 Pavia, Italy. Electronic address: davide.prosperi@unimib.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH